Absorbable Hemostats Market Expected To Grow And Reach $4.95 Billion By 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Absorbable Hemostats Market Expected To Reach Based On Its 2026 Value?

The absorbable hemostats market has experienced significant growth in recent years. Its value is anticipated to rise from $3.37 billion in 2025 to $3.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.8%. The historical expansion of this market can be attributed to factors such as an increasing volume of neurosurgery and orthopedic surgery procedures, a rising demand for products that control intraoperative bleeding, the growing adoption of oxidized regenerated cellulose and gelatin-based hemostats, the expansion of hospital surgical infrastructure and operating rooms, and increasing clinical acceptance of absorbable biomaterial hemostats.

The absorbable hemostats market is projected to experience substantial expansion in the coming years. It is anticipated to reach $4.96 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. This growth during the forecast period is propelled by factors such as the increasing application of advanced thrombin and collagen-based products, a growing inclination towards minimally invasive and reconstructive surgical procedures, heightened investment in novel bioabsorbable and hybrid hemostat solutions, an expansion in the number of procedures conducted in ambulatory surgical centers, and an increased emphasis on minimizing surgical complications and optimizing recovery periods. Key trends anticipated during the same period encompass the advancing development of bioengineered absorbable hemostat materials for improved tissue compatibility, a surging embrace of sophisticated collagen, gelatin, and thrombin-based hemostats in intricate surgical operations, a growing demand for versatile hemostatic products that promote swift clot stabilization and effective wound healing, broadened use of absorbable hemostats in both minimally invasive and reconstructive surgeries, and an intensified clinical emphasis on hemostats engineered to mitigate post-operative complications and risks of surgical bleeding.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18777&type=smp

What Significant Factors Are Influencing The Absorbable Hemostats Market Expansion?

The expansion of the absorbable hemostats market is projected to be driven by an increasing volume of surgical operations. Surgical procedures encompass medical interventions executed to treat, diagnose, or manage conditions by physically altering tissues or organs via incisions or other techniques. This uptick in procedures is attributed to a rising demand for advanced medical treatments, an aging population globally, and advancements in surgical technology enabling more intricate and minimally invasive operations. Absorbable hemostats are vital during these procedures for controlling bleeding and fostering clot formation, as they are gradually absorbed by the body, thereby diminishing the requirement for additional interventions and lessening postoperative complications. For instance, in April 2025, the British Association of Aesthetic Plastic Surgeons, a professional body based in the UK, reported that 25,972 surgical procedures were carried out in 2023. Women represented 93% of all cosmetic surgeries performed, while men constituted the remaining 7% of these cases. Thus, the escalating number of surgical procedures is a primary growth driver for the absorbable hemostats market.

Which Segment Types Are Examined In The Absorbable Hemostats Market Segment Study?

The absorbable hemostats market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Other Types

2) By Application: Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Other Applications

3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Thrombin-Based Hemostats: Lyophilized Thrombin Hemostats, Liquid Thrombin-Based Hemostats

2) By Oxidized Regenerated Cellulose-Based Hemostats: Pre-Packaged Oxidized Cellulose Hemostats, Customizable Oxidized Cellulose Products

3) By Gelatin-Based Hemostats: Gelatin Sponge-Based Hemostats, Gelatin Foam-Based Hemostats

4) By Collagen-Based Hemostats: Collagen-Based Pads or Sheets, Collagen-Based Sponges or Powder

5) By Other Types: Fibrin-Based Hemostats, Polymeric-Based Hemostats, Other Innovative Or Hybrid Formulations

What Trends Are Affecting The Direction Of The Absorbable Hemostats Market?

Leading companies in the absorbable hemostats market are focusing on developing advanced products, such as absorbable hemostatic powder, to ensure quick and effective bleeding control during surgical procedures. This absorbable hemostatic powder is a medical product used to manage bleeding by promoting rapid clot formation at the injury site, and it is naturally absorbed by the body after its function is complete. For example, in July 2023, Baxter International Inc., a US-based healthcare firm, introduced PERCLOT absorbable hemostatic powder. PERCLOT granules feature a distinct molecular structure that quickly absorbs water, creating a gelled adhesive matrix that forms a mechanical barrier to stop bleeding by encouraging the buildup of platelets, red blood cells, and coagulation proteins such as thrombin and fibrinogen. This capability enhances clinicians’ proficiency in managing a wider spectrum of intraoperative bleeding, which is essential for reducing the demand for blood transfusions, minimizing significant complications, and ultimately decreasing the overall cost of patient care.

Which Players Are Part Of The Competitive Landscape Of The Absorbable Hemostats Market?

Major companies operating in the absorbable hemostats market are Johnson & Johnson, Medtronic Plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences, Acelity, Meril Life Sciences Pvt. Ltd., Gelita AG, CryoLife Inc., Anika Therapeutics Inc., Z-Medica LLC, Cohera Medical Inc., Marine Polymer Technologies Inc., Curasan AG, Hemostasis LLC, Arch Therapeutics Inc., Cura Medical, FzioMed Inc., Guizhou Jin Jiu Biotech Co. Ltd., Omrix Biopharmaceuticals Inc.

Get The Full Absorbable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Which Region Leads The Absorbable Hemostats Market In Overall Market Size?

North America was the largest region in the absorbable hemostats market in 2025. The regions covered in the absorbable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Absorbable Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18777&type=smp

Browse Through More Reports Similar to the Global Absorbable Hemostats Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795